Episode 559: SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes
POEM of the Week Podcast - Un pódcast de Mark Ebell and Michael Wilkes
Categorías:
Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes '
